Scott Boyer
Chief Executive Officer at KLARIA PHARMA HOLDING AB
Profile
Scott Boyer is the founder of Nutrinovate AB (founded in 2015) and Klaria Pharma Holding AB (founded in 2015).
He is currently the Chief Executive Officer at Klaria Pharmaceuticals AB, Director-Computational Toxicology at Karolinska Institutet, Director at Computational Toxicology Services LLC, Independent Director at Karessa Pharma Holding AB, Director at Klaria AB, and Managing Director at Chemotargets SL.
He previously worked as the Chief Scientist at AstraZeneca AB.
Dr. Boyer holds a doctorate degree from The University of Colorado.
Scott Boyer active positions
Companies | Position | Start |
---|---|---|
KARESSA PHARMA HOLDING AB (PUBL) | Director/Board Member | 2013-12-31 |
KLARIA PHARMA HOLDING AB | Chief Executive Officer | 2023-10-24 |
Computational Toxicology Services LLC
Computational Toxicology Services LLC Pharmaceuticals: MajorHealth Technology Computational Toxicology Services LLC specializes in toxicity screening of pharmaceuticals. The private company is based in Rockville, MD. | Director/Board Member | - |
Karolinska Institutet | Corporate Officer/Principal | - |
Klaria Pharmaceuticals AB
Klaria Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of Klaria Pharma Holding AB, Klaria Pharmaceuticals AB develops pharmaceuticals. The private company is based in Stockholms, Sweden. The CEO of the Swedish company is Scott Boyer. | Chief Executive Officer | - |
Klaria AB
Klaria AB Pharmaceuticals: MajorHealth Technology Part of Klaria Pharma Holding AB, Klaria AB develops pharmaceuticals. | Director/Board Member | - |
Chemotargets SL
Chemotargets SL Pharmaceuticals: MajorHealth Technology Chemotargets SL is a Spanish company that offers predictive analytics and translational safety solutions for pharmaceutical, biotech, and research institutions. The private company helps to find repurposing options for drugs already approved for certain indications to novel therapeutic uses. The company's innovative data science solution, CLARITY, is used by big and small pharma companies, as well as the FDA for Drug Evaluation and Research. The team at Chemotargets aims to help the biopharma industry speed up the process of bringing new medicines to market while improving safety concerns. The CEO of the company is Scott Boyer. | Chief Executive Officer | - |
Former positions of Scott Boyer
Companies | Position | End |
---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Chief Tech/Sci/R&D Officer | - |
Nutrinovate AB
Nutrinovate AB Household/Personal CareConsumer Non-Durables Nutrinovate AB develops, produces and sells health beauty and dietary supplement products. The company was founded by Scott Boyer and Magnus Nilsson Vall in 2015 and is headquartered in Taby, Sweden. | Founder | - |
Training of Scott Boyer
The University of Colorado | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
KLARIA PHARMA HOLDING AB | Health Technology |
Private companies | 7 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Computational Toxicology Services LLC
Computational Toxicology Services LLC Pharmaceuticals: MajorHealth Technology Computational Toxicology Services LLC specializes in toxicity screening of pharmaceuticals. The private company is based in Rockville, MD. | Health Technology |
Karessa Pharma Holding AB
Karessa Pharma Holding AB Pharmaceuticals: MajorHealth Technology Karessa Pharma Holding AB engages in the development and commercialization of products in the therapeutic area of erectile dysfunction. Its patented drug is an alignate-based polymer film that is applied to the oral mucosa, which then rapidly delivered out into the bloodstream. The company was founded by Fredrik Hubinette on September 11, 2013 and is headquartered in Taby, Sweden. | Health Technology |
Klaria Pharmaceuticals AB
Klaria Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of Klaria Pharma Holding AB, Klaria Pharmaceuticals AB develops pharmaceuticals. The private company is based in Stockholms, Sweden. The CEO of the Swedish company is Scott Boyer. | Health Technology |
Klaria AB
Klaria AB Pharmaceuticals: MajorHealth Technology Part of Klaria Pharma Holding AB, Klaria AB develops pharmaceuticals. | Health Technology |
Nutrinovate AB
Nutrinovate AB Household/Personal CareConsumer Non-Durables Nutrinovate AB develops, produces and sells health beauty and dietary supplement products. The company was founded by Scott Boyer and Magnus Nilsson Vall in 2015 and is headquartered in Taby, Sweden. | Consumer Non-Durables |
Chemotargets SL
Chemotargets SL Pharmaceuticals: MajorHealth Technology Chemotargets SL is a Spanish company that offers predictive analytics and translational safety solutions for pharmaceutical, biotech, and research institutions. The private company helps to find repurposing options for drugs already approved for certain indications to novel therapeutic uses. The company's innovative data science solution, CLARITY, is used by big and small pharma companies, as well as the FDA for Drug Evaluation and Research. The team at Chemotargets aims to help the biopharma industry speed up the process of bringing new medicines to market while improving safety concerns. The CEO of the company is Scott Boyer. | Health Technology |
- Stock Market
- Insiders
- Scott Boyer